EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Nepokupna-Slobodyanyuk Т.S.

    THE EFFECTIVENESS OF LONG-TERM AZITHROMYCIN USING IN NON-SURGICAL THERAPY OF GENERALIZED CHRONIC PERIODONTITIS


    About the author: Nepokupna-Slobodyanyuk Т.S.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The study examines the effectiveness of long term azithromycin in combination with non-surgical periodontal therapy on clinical parameters and IL-1β, AST, ALT concentration levels in periodontal pockets over 360±5 days in patients with generalized chronic periodontitis (CP). Forty patients with generalized chronic periodontitis I, II and III levels of severity were included in this randomized, placebo-controlled, parallel-arm study. They were randomly assigned to azithromycin or placebo groups (500 mg once daily for 7 days, then 500 mg once a week for 12 weeks) of 20 people after initial periodontal treatment and sanation measures. Periodontal clinical parameters (PPD, BoP, CAL, teeth pathological mobility, PMA, hygiene indexes, calculus scores) and IL-1β, AST, ALT concentrations were evaluated before treatment and after 14±3, 30±5, 90±5, 180±5 and 360±5 days. The material for the study of IL-1β, ALT and AST were sample of periodontal pockets content from 1-2 same teeth received with paper pins. Determination of ALT, AST was performed by kinetic photometric (dinitrofenilhidrazyn) method. Determination of ІЛ-1β was performed by solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) method. The long term adjuvant azithromycin provides clinical benefit in 80% of patients with generalized CP I-III levels of severity within 360±5 days with satisfactory tolerability, as confirmed significant decrease in IL-1β, AST, ALT in periodontal pockets.
    Tags chronic generalized periodontitis, azithromycin, interleukin-1 beta
    Bibliography
    • Беркало Л.В. Методи клінічних та експериментальних досліджень в медицині / Л.В. Беркало, О.В. Бобович, Н.О. Боброва [та ін.] // - Полтава: Полімет, - 2003.-319с.
    • Белоклицкая Г.Ф. Современный взгляд на классификации болезней пародонта. Ответ на приглашение к дискуссии, прозвучавшее в статье Данилевский Н.Ф., Борисенко А.В. «Сучасні класифікації захворювань пародонту» в журнале «Імплантологія, пародонтологія, остеологія», - 2006, № 4, С. 59–62.
    • Ключников С.О. Применение макролидов у детей в современных условиях / С.О. Ключников, В.Б. Болдырев // РМЖ.-2007.-№21.-С.1552-1558.Современная стоматология и зубное протезирование. http://www.stomatology.org.ua/modules/myarticles /article.php?item_id=2/.
    • Кайдашев И.П. Очерки иммунобиологии слизистой оболочки полости рта / И.П. Кайдашев, В.И. Шинкевич, Д.М. Король[и др.] / - Полтава: Полимет, - 2008.-304с.
    • Лукьянов С.В. Клиническая фармакология макролидов / С.В. Лукьянов // - Consilium medicum.- 2004.-№ 10.-С.769-773.
    • СинопальниковА.И. Безопасность макролидных антибиотиков: критический аналіз / А.И. Синопальников, И.В. Андреева, О.У. Стецюк // Клиническая медицина.-2012.-№ 3.-С.23-30.
    • Botero J.E. Effects of periodontal non-surgical therapy plus azithromycin on glycemic control in patients with diabetes: a randomized clinical trial / J.E. Botero, F.L. Yepes, S.P. Ochoa [et al.] // J Periodontal Res.-2013.-Vol. 27.
    • Emingil G. Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis / G. Emingil, B. Han, G. Ozdemir [et al.] // J Periodontal Res.-2012.-Vol. 47, N 6.-P.729-739.
    • Gupta G. Gingival crevicular fluid as a periodontal diagnostic indicator- I: Host derived enzymes and tissue breakdown products / G. Gupta // J Med Life.-2012.-Vol. 5, N 4.-P.390-397.
    • Haas A.N. Adjunctive azithromycin in the treatment of aggressive periodontitis: microbiological findings of a 12-month randomized clinical trial / A.N. Haas, C.M. Silva-Boghossian, A.P. Colombo [et al.] // J Dent.-2012.-Vol. 40, N 7.-P.556-563.
    • Lee C.E. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance / C.E. Lee, T.R. Zembower, M.A. Fotis [et al.] // Arch. Intern. Med.-2000.-Vol. 160, N 18.-P. 2819-2822.
    • Muniz F.W. Azithromycin: A new concept in adjuvant treatment of periodontitis / F.W. Muniz, C.C. de Oliveira, R. de Sousa Carvalho [et al.] // Eur J Pharmacol.-2013.-Vol.705, N 1-3.-P.135-139.
    • Pomares X. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations / X. Pomares, C. Monton, M. Espasa [et al.] // Int J Chron Obstruct. Pulm. Dis.-2011.-Vol.6.-P.449-456.
    • Sampaio E. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial / E. Sampaio, M. Rocha, L.C. Figueiredo [et al.] // J Clin Periodontol.-2011.-Vol. 38, N 9.-P.838-846.
    • Wu Y.F. Interleukin-1beta and IL-1 receptor antagonist levels in gingival crevicular fluid and their relationship to clinical indices of periodontitis / Y.F. Wu, C. Tan, J.Y. Zhang [et al.] // Sichuan Da Xue Xue Bao Yi Xue Ban.-2004.-Vol.35, N 5.-P.683-686.
    Publication of the article «World of Medicine and Biology» №1(43), 2014 year, 066-070 pages, index UDK 616.314.17-002.2-08